SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
TGEN - Targeted Genetics Corporation
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
557 30 0 TGEN
Emcee:  Mike McFarland Type:  Moderated
Introduction Market Data Compact
ABOUT TARGETED GENETICS CORPORATION
targen.com

Targeted Genetics Corporation develops and commercializes molecular therapeutics that target the underlying cause of a variety of serious diseases that have significant unmet medical need. Our lead product candidate is being developed as a treatment for inflammatory arthritis, and additional programs target HIV/AIDS, congestive heart failure and Huntington's disease. Our diverse pipeline has been built on a solid foundation of intellectual property related to gene delivery, and on our core capabilities in critical functions that include preclinical development, clinical and regulatory affairs, and manufacturing of innovative gene-based product candidates. These assets and capabilities provide a broad spectrum of potential future market opportunities, as well as partnering or out-licensing opportunities.

Targeted Genetics is based in Seattle, Washington, and has approximately 65 employees. The Company has been public since May 1994 and its stock trades on the NASDAQ Capital Market under the ticker symbol TGEN.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
557.pk --trading around 16 cents, six employeesMike McFarland1/23/2010
556Worth three million dimes more than yesterday, seven million marketcap, no newsMike McFarland12/7/2009
555TGEN facing BK! only down to .28? 1. Targeted Genetics faces bankruptcy By Maumlkr5/8/2009
554Targeted Genetics cuts 7; senior execs’ pay slashed seattle.bizjournals.comMike McFarland12/5/2008
553Latest quarterly report says cash <i> will only be sufficient to fund our Mike McFarland11/18/2008
552Targeted Genetics Announces Presentation of Data From Completed Phase 1/2 tgAAC9Mike McFarland10/27/2008
551Marketcap under $5M and the stock is just two bits --the shares have lost 2/3rdsMike McFarland10/26/2008
550Sorry, I don't follow TGEN and the Translational Genomics Research study belidos9/2/2008
549TGEN and TGen are a thousand miles apart, but don't worry about it. Check oMike McFarland9/2/2008
548Contact: Galen Perry gperry@tgen.org 602-343-8423 The Translational Genomics Residos9/1/2008
547For the quarter ended June 30, 2008, the Company reported a net loss of $3.8 milMike McFarland8/6/2008
546Targeted Genetics to Host Conference Call and Webcast Discussion of First QuarteMike McFarland7/31/2008
54555 cents might have been the low a few days ago. There is a nice writeup here--Mike McFarland7/17/2008
544Pretty sure this price of 60 cents is an all time low (that is 6 cents a share fMike McFarland6/24/2008
543Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual Mike McFarland6/12/2008
542(said nothing about the vaccine work) I have nothing new, but since I was pokinMike McFarland6/10/2008
541I wonder if this quote from back in April is a notch over the top <i>We beMike McFarland6/4/2008
540Confusion over gene therapy trial data blog.seattlepi.nwsource.comMike McFarland6/3/2008
539TGEN announced additional interim data from its Phase 1/2 clinical study of tgAAMike McFarland5/30/2008
538(The Forbes profile says Mr. Bowman is 74 years old, so although things look prMike McFarland5/20/2008
537I listened with IE/WMP, and no slides loaded, but I'm pretty sure there are Mike McFarland5/19/2008
536Webcast--Targeted Genetics at Rodman & Renshaw Annual Global Healthcare ConfMike McFarland5/16/2008
535Quarterly report available here ir.targen.com I see that the enterprise value (Mike McFarland5/9/2008
534(this is old stuff, the PR is from October 2006 apparently, I was just poking arMike McFarland5/6/2008
533Metabolically Activated Recombinant Viral Vectors and Methods for Their PreparatMike McFarland5/5/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News